Lv1
10 积分 2023-05-31 加入
Recent Advances in Scaffold Hopping
2天前
已完结
Discovery of tricyclic PARP7 inhibitors with high potency, selectivity, and oral bioavailability
4天前
已完结
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors
5天前
已完结
Exploring the structural-activity relationship of hexahydropyrazino[1,2-d]pyrido[3,2-b][1,4]oxazine derivatives as potent and orally-bioavailable PARP7 inhibitors
6天前
已完结
Novel PARP7 Inhibitors for Treating Cancer
6天前
已完结
Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and NAMPT for the Treatment of Glioma with IDH1Mutation
6天前
已完结
Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationship
11天前
已完结
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
13天前
已完结
Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
13天前
已完结
Poly(ADP-ribose) polymerase inhibition: past, present and future
13天前
已完结
皖公网安备34019202002308
